Hong Luo

This inventor holds 17 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 9 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Centaurus Biopharma Co., Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Lianyungang Runzhong Pharmaceutical Co., Ltd.. Active years: 2016-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hong Luo. Retrieved from https://idiyas.com/inventor/hong-luo-mrd452nq

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 (Patent Applications = 1)

% Patents Active = 70.6

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 9 (Patent Applications = 14)

Average Co-Inventor Count = 9.0

ph-index = 5

Forward Citations = 63(Granted Patents)

Company Filing History:

13 out of 33

Centaurus Biopharma Co., Ltd.

patents

11 out of 121

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

patents

10 out of 26

Lianyungang Runzhong Pharmaceutical Co., Ltd.

patents

4. 1 out of 1

Centaurus Biophrama Co., Ltd.

patent

5. 1 out of 125

University of Science and Technology Beijing

where one patent can have more than one assignee

Years Active: 2016-2023

Loading Chart...

Areas of Expertise:

Neurotrophic Factor

Tyrosine Kinase

CDK Inhibitor

DPP-IV Inhibitor

Bruton's Tyrosine Kinase

Amino Pyrazolopyrimidine

Pyrrolopyrimidine

Antitumor Compound

Quinazoline Derivative

Selective Estrogen Receptor Modulators

Heterogeneous Computing

Kinase Modulating Compounds

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11555778 - High-flux sensor suitable for corrosion big data monitoring and manufacturing method (2023-01-17),

2. 10829492 - Amino pyrazolopyrimidine compound used as neurotrophic factor tyrosine kinase receptor inhibitor (2020-11-10),

3. 10745383 - 1,3,5-triazine derivative and method of using same (2020-08-18),

4. 10732943 - Programming model of neural network-oriented heterogeneous computing platform (2020-08-04),

5. 10617692 - Pyrrolopyrimidine comprising cyclopentyl substituent (2020-04-14),

6. 10570141 - Substituted pyrrolopyrimidine CDK inhibitor, pharmaceutical composition containing same and use thereof (2020-02-25),

7. 10561657 - Pyrrolopyrimidine compound (2020-02-18),

8. 10329277 - N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(3-methyl-2-OXO-2,3-dihydro-1h-benzo[d]imidazol-1-yl)pyrimidin-2-yl)amino)phenyl)acrylamide hydrochloride as an inhibitor of epidermal growth factor receptor activity (2019-06-25),

9. 10155775 - Substituted amino six-membered saturated heteroalicycles as long-acting DPP-IV inhibitors (2018-12-18),

10. 10155722 - Antitumor compound targeting IDH2 mutation and method of use thereof (2018-12-18),

11. 10112922 - Inhibitor of bruton's tyrosine kinase (2018-10-30),

12. 9926299 - Inhibitors of bruton's tyrosine kinase (2018-03-27),

13. 9725439 - Quinazoline derivative and preparation method therefor (2017-08-08),

14. 9708295 - Substituted 2-aminopyridine protein kinase inhibitor (2017-07-18),

15. 9550781 - Kinase modulating compounds, compositions containing the same and use thereof (2017-01-24),

Title: Inventor Hong Luo - Revolutionizing Technology in Beijing

Introduction: Hong Luo is a visionary inventor based in Beijing, China, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Hong Luo holds several patents in the areas of artificial intelligence, robotics, and renewable energy technologies, showcasing his commitment to pushing the boundaries of technological advancement.

Career Highlights: With a career spanning over two decades, Hong Luo has worked with leading tech companies and research institutions, playing a pivotal role in developing cutting-edge solutions that have revolutionized various industries.

Collaborations: Throughout his career, Hong Luo has collaborated with top engineers, scientists, and researchers from around the world, fostering a culture of innovation and knowledge exchange to drive progress in the tech sector.

Conclusion: Hong Luo's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and technologists, solidifying his legacy as a true pioneer in the field of technology.

Profile summary based on public USPTO records.